RhythmAnalytics vs LINQ II Insertable Cardiac Monitor
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your healthcare organization needs an AI-powered cloud-based solution for rapid and accurate interpretation of cardiac arrhythmias from diverse single-lead ECG data sources. This tool is ideal for enhancing clinical decision support by automating the analysis of ECGs from existing FDA-cleared devices like Holter monitors, event recorders, or wearable sensors, improving diagnostic efficiency and reducing errors.
View RhythmAnalytics →Choose LINQ II Insertable Cardiac Monitor if…
Choose the LINQ II Insertable Cardiac Monitor if you require a long-term, continuous heart rhythm monitoring solution for patients experiencing infrequent or elusive symptoms that suggest a cardiac arrhythmia. This AI-powered insertable device provides up to 4.5 years of unobtrusive monitoring, making it particularly well-suited for diagnosing conditions like unexplained syncope, cryptogenic stroke, or suspected atrial fibrillation, even in pediatric patients aged 2 and older.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Contact vendor | Enterprise |
| Deployment | Cloud-based API | Hybrid |
| FDA Status | 1 AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
RhythmAnalyticsRhythmAnalytics, as a cloud-based API, integrates into existing workflows and devices, potentially offering a more seamless experience for clinicians by enhancing their current tools. Its usability focuses on improving the accuracy and scalability of ECG analysis within familiar systems.
Clinical Value
LINQ II Insertable Cardiac MonitorLINQ II offers significant clinical value through its ability to provide continuous, long-term heart rhythm monitoring for up to 4.5 years, crucial for detecting infrequent arrhythmias. Its AccuRhythm AI algorithms also demonstrably reduce false alerts, improving diagnostic efficiency and clinician workflow.
Pricing & Value
TieBoth tools lack publicly disclosed pricing, making a direct comparison of cost and value challenging. While LINQ II involves a higher upfront cost due to the implantable device, studies suggest it offers long-term value through improved patient outcomes. RhythmAnalytics, as a SaaS API, likely offers a more flexible model, but without concrete pricing, neither can be definitively declared a winner.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic's long history, global presence, and vast customer base of over a million patients for its ICMs demonstrate a superior level of established enterprise readiness. Their comprehensive support infrastructure and experience with large health systems provide a strong advantage.
Innovation
LINQ II Insertable Cardiac MonitorLINQ II demonstrates greater innovation through its groundbreaking AccuRhythm AI algorithms for false alert reduction, extended 4.5-year continuous monitoring, and the pioneering use of wafer-scale manufacturing for an implantable device. These advancements have been recognized by industry awards.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic, as a well-established global medical device company, provides a comprehensive and multi-faceted support system for both clinicians and patients, including dedicated phone lines, educational resources, and patient-facing app support. This mature infrastructure is more extensive than the enterprise-level IT support offered by Biofourmis.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Product Name | RhythmAnalytics | LINQ II Insertable Cardiac Monitor |
| Company | Biofourmis Singapore Pte. | Medtronic |
| Primary Function | AI-powered cloud-based software for automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. | Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. |
| Core Data Source / Device Type | Automated interpretation of cardiac arrhythmias from single-lead ECG data (compatible with FDA-cleared ECG devices like Holter, event recorders, wearable sensors) | Insertable cardiac monitor for continuous heart rhythm monitoring |
| Key AI Capability | AI-based automated interpretation of cardiac arrhythmias; Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) | AccuRhythmu2122 AI algorithms for enhanced accuracy; Innovative PVC detection algorithm |
| Monitoring Duration | Not specified | Up to 4.5 years of continuous monitoring |
| Mobile App / Connectivity | Not specified (Cloud-based API for integration) | MyCareLink Heartu2122 mobile app for data transmission; MyCareLink Relayu2122 home communicator option |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and LINQ II Insertable Cardiac Monitor.